As of 11:25:10 AM EST. Market Open.
Key Executives
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Ralph Schiess Ph.D. | Interim CEO & Chief Science Officer | -- | -- | 1979 |
| Ms. Karina M. Fedasz | Interim Chief Financial Officer | -- | -- | 1973 |
| Dr. Brian Price Ph.D. | Head of Technology Strategy | 126.48k | -- | -- |
| Mr. Andrew D. Skibo Ph.D. | Global Head of Biologics Operations | -- | -- | -- |
| Mr. Theodore Scott Yoho | Head of Business Development | -- | -- | -- |
| Dr. Ali I. Fattom Ph.D. | Head of Science & Discovery | -- | -- | -- |
| Dr. Jay Newmark M.B.A., M.D. | Chief Medical Officer | -- | -- | -- |
| Mr. Christian Bruhlmann | Chief Strategy Officer & GM of Europe | -- | -- | 1977 |
| Dr. Donald L. Very Jr., Ph.D. | Senior VP of Commercial Research & Development | -- | -- | -- |
Onconetix, Inc.
201 East Fifth Street
Suite 1900
Cincinnati, OH 45202
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 12
Description
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Corporate Governance
Onconetix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 20, 2024 at 12:00 AM UTC
Onconetix, Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
AZTR Azitra, Inc.
0.4170
+0.49%
WINT Windtree Therapeutics, Inc.
0.3181
-0.66%
COEP Coeptis Therapeutics Holdings, Inc.
0.1422
+0.49%
VRPX Virpax Pharmaceuticals, Inc.
0.3350
+1.51%
ZVSA ZyVersa Therapeutics, Inc.
1.2000
+5.26%
ADTX Aditxt, Inc.
0.2100
+12.84%
SPRC SciSparc Ltd.
0.1998
-6.33%
PCSA Processa Pharmaceuticals, Inc.
0.8576
+0.89%
NBY NovaBay Pharmaceuticals, Inc.
0.4958
-6.44%
REVB Revelation Biosciences, Inc.
0.3033
+2.83%